18F-labeled folic acid derivatives for imaging of the folate receptor via positron emission tomography

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 56, Issue 9-10, 2013, Pages 432-440

  Schieferstein, Hanno ^a   Ross, Tobias L ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Folate receptor; Folic acid; PET imaging; Radiofolates

Indexed keywords

DIAGNOSIS; ORGANIC ACIDS; PARTICLE BEAMS; POSITRONS;

ACID DERIVATIVE; AUTOIMMUNE DISEASE; FOLATE RECEPTOR; FOLATES; FOLIC ACIDS; HEALTHY TISSUES; INFLAMMATORY DISEASE; POSITRON EMISSION TOMOGRAPHY IMAGING; RADIOFOLATE; TOMOGRAPHY IMAGING;

POSITRON EMISSION TOMOGRAPHY;

2 FLUORO 2 DEOXYGLUCOPYRANOSYL AZIDE F 18; 2' FLUOROFOLIC ACID F 18; 3' AZA 2' FLUOROFOLIC ACID F 18; ALPHA FLUOROBENZYLAMINE F 18; CLICK FOLATE F 18; FLUORINE 18; FLUOROBENZENECARBOHYDRAZIDE FOLATE F 18; FLUORODEOXYGLUCOSE CLICK FOLATE F 18; FLUOROHEX 1 YNE F 18; FLUOROPYRIDINECARBOHYDRAZIDE FOLATE F 18; FOLATE RECEPTOR; FOLIC ACID DERIVATIVE; GAMMA (4-AZIDO BUTYL)FOLIC ACID AMIDE F 18; GAMMA FLUOROBENZYLAMINE F 18; GAMMA FLUOROFOLIC ACID F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR IMAGING; NONHUMAN; PHARMACOLOGICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY;

18F-FOLATES; FOLATE RECEPTOR; FOLIC ACID; PET IMAGING; RADIOFOLATES;

ANIMALS; FLUORINE RADIOISOTOPES; FOLIC ACID; FOLIC ACID TRANSPORTERS; HUMANS; ISOTOPE LABELING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84894340934     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.3104     Document Type: Article

References (22)

1. A. C. Antony, Annu. Rev. Nutr. 1996, 16, 501.
2. H. Yuasa, K. Inoue, Y. Hayashi, J. Pharm. Sci. 2009, 98, 1608.
3. N. Parker, M. J. Turk, E. Westrick, J. D. Lewis, P. S. Low, C. P. Leamon, Anal. Biochem. 2005, 338, 284.
4. J. W. van der Heijden, R. Oerlemans, B. A. Dijkmans, H. Qi, C. J. van der Laken, W. F. Lems, A. L. Jackman, M. C. Kraan, P. P. Tak, M. Ratnam, G. Jansen, Arthritis Rheum. 2009, 60, 12.
5. P. S. Low,W.A.Henne, D. D. Doorneweerd, Acc. Chem. Res. 2008, 41, 120.
6. C. Y. Ke, C. J. Mathias, M. A. Green, Adv. Drug Delivery Rev. 2004, 56, 1143.
7. C. Müller, R. Schibli, J. Nucl. Med. 2011, 52, 1.
8. A. Bettio, M. Honer, C. Müller, M. Brühlmeier, U. Müller, R. Schibli, V. Groehn, A. P. Schubiger, S. M. Ametamey, J. Nucl. Med. 2006, 47, 1153.
9. I. Al Jammaz, B. Al-Otaibi, S. Okarvi, J. Amartey, J. Label. Compd. Radiopharm. 2006, 49, 125.
10. I. Al Jammaz, B. Al-Otaibi, S. Amer, S. M. Okarvi, J. Amartey, Nucl. Med. Biol. 2011, 38, 1019.
11. T. L. Ross, Curr. Radiopharm. 2010, 3, 202.
12. T. L. Ross, M. Honer, P. Y. H. Lam, T. L. Mindt, V. Groehn, R. Schibli, P. A. Schubiger, S. M. Ametamey, Bioconjugate Chem 2008, 19, 2462.
13. S. Maschauer, O. Prante, Carbohydr. Res. 2009, 344, 753.
14. C. R. Fischer, C. Müller, J. Reber, A. Müller, S. D. Krämer, S. M. Ametamey, R. Schibli, Bioconjugate Chem. 2012, 23, 805.
15. I. Al Jammaz, B. Al-Otaibi, S. Amer, N. Al-Hokbany, S. Okarvi, Nucl. Med. Biol. 2012, 39, 864.
16. H. Schieferstein, T. Betzel, C. R. Fischer, T. L. Ross, Eur. J. Nucl. Med. Mol. Imag. Res. 2013, submitted.
17. Y. Y. J. Gent, K. Weijers, C. F. M. Molthoff, A. D. Windhorst, M. C. Huisman, D. E. C. Smith, S. A. Kularatne, G. Jansen, P. S. Low, A. A. Lammertsma, C. J. van der Laken, Arthritis Res. Ther. 2013, 15, doi:10.1186/ar4191.
18. T. L. Ross, M. Honer, C. Müller, V. Groehn, R. Schibli, S. M. Ametamey, J. Nucl. Med. 2010, 51, 1756.
19. V. Groehn, R. Moser, T. L. Ross, T. Betzel, C. Müller, R. Schibli, S. M. Ametamey, Synthesis 2011, 3639.
20. C. Hansch, A. Leo, R. W. Taft, Chem. Rev. 1991, 91, 165.
21. R. Schibli, R. Moser, C. M. Müller, S. M. Ametamey, T. L. Ross, V. Groehn, Int. Pat. 2009. WO 2010/040854.
22. T. Betzel, C. Müller, V. Groehn, A. Müller, J. Reber, C. R. Fischer, S. D. Krämer, R. Schibli, S. M. Ametamey, Bioconjugate Chem. 2013, 24, 205.